Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
BMC Res Notes ; 17(1): 163, 2024 Jun 13.
Article in English | MEDLINE | ID: mdl-38872196

ABSTRACT

PURPOSE: This study aimed to evaluate the knowledge, attitude, and practice toward iron chelating agents (ICAs) in Iranian thalassemia major patients. METHODS: A total of 101 patients with thalassemia major were involved in this cross-sectional survey. A deep medication review was done, and participants' knowledge, attitude, and practice were evaluated by a validated instrument based on a 20-scoring system. RESULTS: Statistical analyses showed 52 patients (51.5%) had a poor knowledge level (scores < 10) about their medications, 37 (36.6%) had a moderate level (scores 10-15), and 12 (11.9%) had a satisfactory level (scores > 15). Seventy-seven (76.2%) patients have positive beliefs regarding the dependence of their current health status on taking iron chelators, and 63 (62.4%) believed that they would become very ill without taking medication. The results also showed that the mean practice score in patients who received deferoxamine was 5.81 ± 3.50; in the patients who received deferiprone and those who received deferasirox, the mean scores were 7.36 ± 5.15 and 14.94 ± 4.14. Also, the knowledge and practice level had a direct linear correlation based on the regression analyses (P < 0.001). CONCLUSION: In conclusion, results of the present research suggests that the patients' knowledge about the administration, adverse events, and necessity of ICAs was not satisfactory. Improving the knowledge of thalassemia patients toward their medicines through educational interventions is highly recommended to improve their practice level.


Subject(s)
Health Knowledge, Attitudes, Practice , Iron Chelating Agents , Humans , Iron Chelating Agents/therapeutic use , Iran , Male , Female , Adult , Cross-Sectional Studies , Young Adult , Adolescent , beta-Thalassemia/drug therapy , Thalassemia/drug therapy , Deferiprone/therapeutic use , Deferasirox/therapeutic use , Deferoxamine/therapeutic use , Triazoles/therapeutic use , Middle Aged , Pyridones/therapeutic use
2.
Int J Nanomedicine ; 14: 5355-5368, 2019.
Article in English | MEDLINE | ID: mdl-31409992

ABSTRACT

AIM: Nanoparticles (NPs) have been receiving potential interests in protein delivery and cell therapy. As a matter of fact, NPs may be used as great candidates in promoting cell therapy by catalase (CAT) delivery into high oxidative stress tissues. However, for using NPs like SiO2 as carriers, the interaction of NPs with proteins and mesenchymal stem cells (MSCs) should be explored in advance. METHODS: In the present study, the interaction of SiO2 NPs with CAT and human MSCs (hMSCs) was explored by various spectroscopic methods (fluorescence, circular dichroism (CD), UV-visible), molecular docking and dynamics studies, and cellular (MTT, cellular morphology, cellular uptake, lactate dehydrogenase, ROS, caspase-3, flow cytometry) assays. RESULTS: Fluorescence study displayed that both dynamic and static quenching mechanisms and hydrophobic interactions are involved in the spontaneous interaction of SiO2 NPs with CAT. CD spectra indicated that native structure of CAT remains stable after interaction with SiO2 NPs. UV-visible study also revealed that the kinetic parameters of CAT such as Km, Vmax, Kcat, and enzyme efficiency were not changed after the addition of SiO2 NPs. Molecular docking and dynamics studies showed that Si and SiO2 clusters interact with hydrophobic residues of CAT and SiO2 cluster causes minor changes in the CAT structure at a total simulation time of 200 ps. Cellular assays depicted that SiO2 NPs induce significant cell mortality, change in cellular morphology, cellular internalization, ROS elevation, and apoptosis in hMSCs at higher concentration than 100 µg/mL (170 µM). CONCLUSION: The current results suggest that low concentrations of SiO2 NPs induce no substantial change or mortality against CAT and hMSCs, and potentially useful carriers in CAT delivery to hMSC.


Subject(s)
Biophysical Phenomena , Mesenchymal Stem Cells/cytology , Models, Theoretical , Nanoparticles/chemistry , Silicon Dioxide/pharmacology , Apoptosis/drug effects , Caspase 3/metabolism , Catalase/metabolism , Cell Shape/drug effects , Circular Dichroism , Endocytosis/drug effects , Humans , Kinetics , L-Lactate Dehydrogenase/metabolism , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Molecular Docking Simulation , Molecular Dynamics Simulation , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Spectrometry, Fluorescence , Thermodynamics
3.
Int J Biol Macromol ; 106: 78-86, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28818722

ABSTRACT

In this paper, the conformational changes of cytochrome c (cyt c) upon interaction with manganese nanoparticle (Mn-NP) were examined using dynamic light scattering (DLS), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), zeta potential, fluorescence spectroscopy, and circular dichroism (CD) spectroscopy methods. DLS and TEM analysis exhibited the structure of Mn-NP was less than 50nm. FTIR bands were similar to those reported for Mn-NP. Zeta potential measurements showed positive charge distribution for Mn-NP (4.71±0.71mV) at pH 7.8. It was revealed that the mechanism of fluorescence quenching incorporated both dynamic and static quenching. Also, binding site and binding constant increased as the temperature is raised. The positive sign of ΔH° and ΔS° suggested that hydrophobic forces are indicative forces in the interaction between cyt c and Mn-NP. Synchronous fluorescence spectra revealed that the conformation of protein was not perturbed around tryptophan (Trp) and tyrosine (Tyr) residues. CD analysis suggested that there was a conformational change at tertiary structure levels of cyt c in the vicinity of phenylalanine (Phe) residues, while the secondary structure of protein was not altered. This study facilitates a deeper insight on the interaction mechanisms between NPs and biological macromolecules.


Subject(s)
Cytochromes c/chemistry , Manganese/chemistry , Metal Nanoparticles/chemistry , Phenylalanine/chemistry , Tryptophan/chemistry , Tyrosine/chemistry , Amino Acid Sequence , Animals , Binding Sites , Cattle , Hydrophobic and Hydrophilic Interactions , Models, Molecular , Particle Size , Protein Binding , Protein Structure, Secondary , Protein Structure, Tertiary , Spectrum Analysis/methods , Static Electricity , Temperature , Thermodynamics
4.
J Diet Suppl ; 13(6): 616-25, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27077696

ABSTRACT

PURPOSE: We have investigated the association between markers of renal function [serum urea nitrogen, creatinine, and estimated glomerular filtration rate (eGFR)] and age and lipid profile in an Iranian population sample of 4,567 subjects. MATERIALS/METHODS: Serum creatinine and urea nitrogen, together with anthropometric parameters and lipid profile were determined in all the subjects. eGFR was calculated using the modification of diet in renal disease formula. RESULTS: Serum creatinine and urea nitrogen increased with age (p < .05), and this relationship was also more pronounced in men compared to women. Increased levels of these renal function markers were significantly associated with altered lipid profiles. CONCLUSION: Levels of renal function markers increased with age and were associated with altered lipid profile.


Subject(s)
Aging/physiology , Kidney/physiology , Lipids/blood , Adult , Biomarkers/blood , Blood Urea Nitrogen , Body Mass Index , Creatinine/blood , Female , Glomerular Filtration Rate , Humans , Iran , Male , Middle Aged , Sex Factors , Smoking
5.
Adv Med Sci ; 61(2): 219-223, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26907695

ABSTRACT

PURPOSE: There is now good evidence that 25-hydroxyvitamin D (25OHD) status may have an important impact on the development and progression of cardiovascular disease. Because of the potential involvement of vitamin D deficiency in blood pressure control and immune responses, we aimed to investigate whether there was a relationship between 25OHD status and the prevalence of metabolic syndrome in an Iranian population. MATERIAL/METHODS: The study was carried out on a sample of 846 subjects [357(42.19%) males and 489(57.80%) females], derived from MASHAD STUDY. Serum 25OHD levels were measured using a competitive electroluminescence protein binding assay. Anthropometric indices were measured using standard protocols. RESULTS: Serum 25OHD was 12.7 (6.8-18.4) ng/ml in the metabolic syndrome (MetS) group and 14.1 (8.8-19.0) ng/ml in the group without metabolic syndrome (P=0.43). The frequency of vitamin D deficiency was 80.7% and 79.0% in subjects with or without metabolic syndrome in Iranian population. CONCLUSIONS: We found no significant difference in serum 25OHD concentrations between individuals with or without MetS and no significant linear relationship between serum 25OHD and several CVD risk factors.


Subject(s)
Metabolic Syndrome/blood , Metabolic Syndrome/epidemiology , Vitamin D/analogs & derivatives , Adiposity , Body Mass Index , Female , Humans , Linear Models , Male , Middle Aged , Multivariate Analysis , Prevalence , Triglycerides/blood , Vitamin D/blood
6.
J Epidemiol Community Health ; 69(6): 594-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25631859

ABSTRACT

OBJECTIVE: The global prevalence of metabolic syndrome (MetS) appears to be increasing and the impact of this condition on potential comorbidities such as cardiovascular disease is high. Chronic kidney disease (CKD) is also a potential comorbidity of MetS but the method of screening for this is somewhat controversial. Thus, predictive markers that can predict the risk of developing CKD are warranted for identification of patients with MetS at an increased risk. RESEARCH METHODS/PATIENTS: We investigated the occurrence of CKD in 6492 individuals, either with or without MetS. RESULTS: Our results showed that the prevalence of CKD was markedly higher in those individuals with MetS, and increased progressively with the number of MetS components and age. Waist circumference, triglycerides and high-density lipoprotein cholesterol were significantly (p<0.05) associated with altered levels of urea nitrogen, glomerular filtration rate and creatinine, and were related to the increased risk of CKD (eg, OR 1.293 (95% CI 1.10 to 1.52; p=0.002)). The relative risk of CKD remained statistically significant for uric acid following multivariate analyses and adjusting for MetS-associated factors. CONCLUSIONS: Our data demonstrated the association of MetS components with CKD in our population and revealed that susceptibility to CKD was increased with the number of defining features of MetS. These findings prompt prospective studies to determine the impact of preventing and detecting MetS on the risk of developing CKD.


Subject(s)
Evidence-Based Medicine , Metabolic Syndrome/epidemiology , Renal Insufficiency, Chronic/epidemiology , Age Distribution , Biomarkers , Blood Urea Nitrogen , Case-Control Studies , Comorbidity , Creatinine/blood , Disease Progression , Early Diagnosis , Female , Glomerular Filtration Rate , Humans , Iran/epidemiology , Lipoproteins, HDL/blood , Logistic Models , Male , Metabolic Syndrome/diagnosis , Metabolic Syndrome/prevention & control , Middle Aged , Predictive Value of Tests , Prevalence , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/prevention & control , Risk Assessment , Sex Distribution , Triglycerides/blood , Waist Circumference
SELECTION OF CITATIONS
SEARCH DETAIL